(Q42217408)

18 October 2017

title

Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients (English)

1 reference

18 October 2017

1 reference

Greenberg A

1

1 reference

18 October 2017

Egel JW

2

1 reference

18 October 2017

Thompson ME

3

1 reference

18 October 2017

Hardesty RL

4

1 reference

18 October 2017

Griffith BP

5

1 reference

18 October 2017

Bahnson HT

6

1 reference

18 October 2017

Bernstein RL

7

1 reference

18 October 2017

Hastillo A

8

1 reference

18 October 2017

Hess ML

9

1 reference

18 October 2017

Puschett JB

10

1 reference

18 October 2017

publication date

1 January 1987

1 reference

American Journal of Kidney Diseases

18 October 2017

published in

1 reference

18 October 2017

volume

9

1 reference

18 October 2017

issue

1

1 reference

18 October 2017

page(s)

12-22

1 reference

Cyclosporine: Five Years' Experience in Cadaveric Renal Transplantation

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Liver transplantation with use of cyclosporin a and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Side effects of systemic cyclosporine in patients not undergoing transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Cyclosporin A in patients receiving renal allografts from cadaver donors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Cyclosporine-associated chronic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Correlation of serum cyclosporine concentration with renal dysfunction in marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Clinical evaluation of kidney function--glomerular function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low doses in early post-transplantation period

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Chronic irreversible nephrotoxicity from cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Psychosocial influences on mortality after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

A controlled trial of cyclosporine in renal transplantation with conversion to azathioprine and prednisolone after three months

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Reversibility of cyclosporin nephrotoxicity after three months' treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Hospital-acquired renal insufficiency: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Conversion from cyclosporine to azathioprine in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Aspirin-induced depression of glomerular filtration rate in normal humans: role of sodium balance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Elevated urinary prostaglandins and the effects of aspirin on renal function in lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Toxicity of the immune suppressant cyclosporin A in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Nature of the toxicity of cyclosporin A in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Pathological changes developing in the rat during a 3-week course of high dosage cyclosporin A and their reversal following drug withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

The Serum Levels and Urinary Excretion of β2-Microglobulin in Apparently Healthy Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Investigations into the mechanisms of hyperkalemia following renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Impaired Renal Tubular Potassium Secretion in Sickle Cell Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Hyperkalaemia in cyclosporin-treated renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980156-7

7 January 2021

10.1016/S0272-6386(87)80156-7

Identifiers

DOI

1 reference

18 October 2017

1 reference